DIA Biosimilars 2013

GenturaDx

Luminex to acquire GenturaDx

Monday, July 9, 2012 03:34 PM

Luminex, a developer of proprietary instruments and assays, has signed an agreement to acquire GenturaDx, a Hayward, Calif.-based molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory.

More... »

Cenduit: Now with Patient Reminders

GenturaDx names scientific advisory board

Tuesday, November 29, 2011 11:51 AM

GenturaDx has created its scientific advisory board with three initial members: Dr. Keith Jerome, Dr. Steven Miller, and Dr. Gregory Tsongalis. The board will provide expert perspectives across science, laboratory medicine and the commercial market related to initial test development and future applications of the company's proprietary IDbox(TM). The IDbox system is set to begin clinical trials in 2012.

More... »

CRF Health – eCOA Forum
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs